|
Research
Vital Prospects Clinical Research Institute, P.C.
We are a dedicated research center. Founded in 2007, we have become a premier multidisciplinary research center for the state of Oklahoma. We are committed to promoting patient care through the research of innovative therapies. We serve as an educational resource for the patient as well as health care professionals. We have many current ongoing and/or open enrollment in multiple therapeutic trials. Contact us and/or visit this website for more information.
A Phase 3, Randomized, Double-Blind, Placebo Controlled study to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma who are on inhaled corticosteroids and a second controller medication. Non-Invasive Neurostimulation of the vagus nerve with the AlphaCore Device for the relief of Acute Bronchocontriction due to asthma. Evaluation of the Clinical Performance of the iNAT system for the detection of Influenza A&B. A prospecive, multi-center study to examine natural prevalance and/or emergence of resistance to antivirals among influenza virus isolates and of clinical outcome of patients with influenza. Clinical Study to Assess the Efficacy and Safety of DF289 plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients with ear tubes. Acute Otitis Media With Tubes (Ear Infection)
- 6 months to 12 years
- ear tube in the ear which will be treated
- otorrhea for 3 weeks or less
- moderate or severe otorrhea
MORE INFO CONTACT INFO GSK Summit HZC113782 COPD clinical outcomes study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder with placebo on survivial in subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increa PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE)
Sponsored by National Heart, Lung, and Blood Institute (NHLBI)with Duke Clinical Research Institute New Chest Pain Presentation
A prospective multicenter imaging study for evaluation of chest pain. Objective is to determine whether an initial non-invasive anatomic imaging strategy with coronary CT angiography (CTA) will improve clinical outcomes in sub
- Men and women 45-65 years old and willing to give consent
- New or worsening chest pain suspicious for clinical significant CAD
- No prior evaluation for this episode of symptoms
- Planned non-invasive testing for diagnosis
MORE INFO CONTACT INFO |